1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Branded Generics Market – By Therapeutic Application

1.3.2        Europe Branded Generics Market – By Distribution Channel

1.3.3        Europe Branded Generics Market – By Drug Class

1.3.4        Europe Branded Generics Market – By Formulation Type

1.3.5        Europe Branded Generics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Branded Generics Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Branded Generics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Popularity of Branded Generics

5.1.2        Rise in Government Initiatives for Promoting Branded Generics

5.2         Market Restraints

5.2.1        Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications

5.3         Market Opportunities

5.3.1        New Opportunities Owing to Product Differentiation

5.4         Future Trends

5.4.1        More Focus Upon Utility of Branded Generics by Healthcare Providers and Professionals

5.5         Impact Analysis

6.           Branded Generics Market– Europe Analysis

6.1         Europe Branded Generics Market Revenue Forecast and Analysis

6.2         Europe Branded Generics Market, By Country - Forecast and Analysis

7.           Europe Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application

7.1         Overview

7.2         Europe Branded Generics Market Revenue Share, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)

7.3         Oncology

7.3.1        Overview

7.3.2        Oncology Market Revenue and Forecast to 2028 (US$ Billion)

7.4         Cardiovascular Diseases

7.4.1        Overview

7.4.2        Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.5         Diabetes

7.5.1        Overview

7.5.2        Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

7.6         Neurology

7.6.1        Overview

7.6.2        Neurology Market Revenue and Forecast to 2028 (US$ Billion)

7.7         Gastrointestinal Diseases

7.7.1        Overview

7.7.2        Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.8         Dermatology Diseases

7.8.1        Overview

7.8.2        Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.9         Analgesics and Anti-Inflammatory

7.9.1        Overview

7.9.2        Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

7.10      Others

7.10.1     Overview

7.10.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

8.           Europe Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel

8.1         Europe Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

8.2         Hospital Pharmacies

8.2.1        Overview

8.2.2        Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.3         Retail Pharmacies

8.3.1        Overview

8.3.2        Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.4         Online Pharmacies

8.4.1        Overview

8.4.2        Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.5         Drug Stores

8.5.1        Overview

8.5.2        Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.           Europe Branded Generics Market Analysis and Forecast to 2028 by Drug Class

9.1         Europe Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

9.2         Alkylating Agents

9.2.1        Overview

9.2.2        Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.3         Antimetabolites

9.3.1        Overview

9.3.2        Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.4         Hormones

9.4.1        Overview

9.4.2        Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.5         Anti-hypertensive

9.5.1        Overview

9.5.2        Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.6         Lipid Lowering Drugs

9.6.1        Overview

9.6.2        Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.7         Anti-Depressants

9.7.1        Overview

9.7.2        Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.8         Anti-psychotics

9.8.1        Overview

9.8.2        Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.9         Anti-epileptic

9.9.1        Overview

9.9.2        Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.10      Others

9.10.1     Overview

9.10.2     Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10.        Europe Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type

10.1      Overview

10.2      Europe Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Billion)

10.4      Parenteral

10.4.1     Overview

10.4.2     Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

10.5      Topical

10.5.1     Overview

10.5.2     Topical Market Revenue and Forecast to 2028 (US$ Billion)

10.6      Others

10.6.1     Overview

10.6.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

11.        Europe Branded Generics Market Revenue and Forecasts to 2028 Country Analysis

11.1      Overview

11.1.1     Europe: Branded Generics Market, by Country, 2022 & 2028 (%)

11.1.1.1       Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.1       Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.2       Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.3       Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.4       Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.5       Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2       France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.1       France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.2       France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.3       France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.4       France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.5       France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3       UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.1       UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.2       UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.3       UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.4       UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.5       UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4       Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.1       Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.2       Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.3       Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.4       Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.5       Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5       Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.1       Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.2       Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.3       Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.4       Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.5       Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6       Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.1       Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.2       Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.3       Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.4       Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.5       Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

12.        Branded Generics Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      MYLAN N.V.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bausch Health Companies Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Lupin

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Sanofi

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      ASTRAZENECA PLC.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Dr. Reddy's Laboratories

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Par Pharmaceuticals, INC

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Sandoz International GMBH

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Aspen Holdings

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

13.12   Hetero

13.12.1  Key Facts

13.12.2  Business Description

13.12.3  Products and Services

13.12.4  Financial Overview

13.12.5  SWOT Analysis

13.12.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 2.             Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 3.             Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 4.             Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 5.             France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 6.             France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 7.             France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 8.             France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 9.             UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 10.          UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 11.          UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 12.          UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 13.          Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 14.          Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 15.          Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 16.          Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 17.          Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 18.          Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 19.          Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 20.          Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 21.          Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 22.          Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 23.          Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 24.          Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done By Companies

Table 27.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Branded Generics Market Segmentation

Figure 2.           Europe Branded Generics Market, By Country

Figure 3.           Europe Branded Generics Market Overview

Figure 4.           Others Segment Held Largest Share of Drug Class Segment in Europe Branded Generics Market

Figure 5.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints on Europe Branded Generics Market

Figure 9.           Europe Branded Generics Market – By Country Forecast and Analysis – 2019 - 2028

Figure 10.        Europe Branded Generics Market Revenue Share, By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)

Figure 11.        Europe Oncology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 12.        Europe Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 13.        Europe Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

Figure 14.        Europe Neurology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 15.        Europe Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 16.        Europe Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 17.        Europe Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

Figure 18.        Europe Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 19.        Europe Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

Figure 20.        Europe Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 21.        Europe Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 22.        Europe Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 23.        Europe Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 24.        Europe Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

Figure 25.        Europe Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 26.        Europe Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 27.        Europe Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 28.        Europe Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 29.        Europe Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 30.        Europe Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 31.        Europe Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 32.        Europe Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 33.        Europe Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 34.        Europe Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

Figure 35.        Europe Oral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 36.        Europe Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 37.        Europe Topical Market Revenue and Forecast to 2028 (US$ Billion)

Figure 38.        Europe Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 39.        Europe: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)

Figure 40.        Europe: Branded Generics Market, by Country, 2022 & 2028 (%)

Figure 41.        Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 42.        France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 43.        UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 44.        Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 45.        Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 46.        Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 47.        Growth Strategies Done by the Companies in the Market (%)